SCHEMBL6645696

SCHEMBL6645696

C[Si](C)(C)OC(O)(CCO)O[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6681852 0.85 SMN1; SMN2 (0.32)
SCHEMBL4587444 0.76
SCHEMBL4587475 0.74
SCHEMBL4585951 0.72
SCHEMBL10701009 0.69
SCHEMBL4586133 0.68
SCHEMBL15557031 0.65 ALDH1A1 (0.33)
SCHEMBL4586407 0.64
SCHEMBL4586136 0.63
SCHEMBL31511305 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0927183-B1 SPIROCYCLIC METALLOPROTEASE INHIBITORS PROCTER & GAMBLE (US) 2004-07-28 EP disclosed
US-6015912-A TREATING ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS, SKIN DISORDERS, OCULAR DISORDERS, INFLAMMATION, GUM DISEASE THE PROCTER & GAMBLE COMPANY (US) 2000-01-18 US disclosed